Prenatal Testing & Newborn Screening Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted CAGR for the Prenatal Testing & Newborn Screening Market Over the Forecast Period of 2025 to 2034?
There has been significant expansion in the prenatal testing & newborn screening market in the past few years. The market is projected to increase from $6.24 billion in 2024 to $6.99 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. Factors such as progress in genetic testing, higher maternal age, increased awareness and education, and health policy and laws, have all contributed to the historical growth.
The market size for prenatal testing and newborn screening is projected to experience a swift expansion in the coming years, escalating to $11.08 billion in 2029 with a compound annual growth rate (CAGR) of 12.2%. The reason for this growth in the projected period can be traced back to advancements in genetic counseling, cutting-edge technology, point-of-care testing, telemedicine, and remote monitoring. The forecast period is also anticipated to witness trends such as non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), virtual medical consultations, testing of maternal blood, and screening for hemoglobinopathies and sickle cell diseases.
What Combination of Drivers Is Leading to Accelerated Growth in the Prenatal Testing & Newborn Screening Market?
The rise of genetic diseases in newborns has significantly fuelled the growth of the prenatal testing and newborn screening market. The World Health Organization identifies genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome and Huntington’s disease. Sickle cell anemia, a ubiquitous genetic disease, affects millions globally, particularly those of African, American, Cuban, Central American, Saudi Arabian and Indian descent. For instance, research conducted by the Rady Children’s Institute for Genomic Medicine in February 2023 revealed that 41% of infant deaths at Rady Children’s Hospital were linked to single-locus genetic diseases. This significant prevalence of genetic diseases in infants has driven demand for the prenatal testing & newborn screening market.
Explore Comprehensive Insights Into The Global Prenatal Testing & Newborn Screening Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp
Who Are the Top Companies Driving Innovation and Growth in the Prenatal Testing & Newborn Screening Market?
Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.
What Are the Key Emerging Trends in the Prenatal Testing & Newborn Screening Market for the Next Decade?
Key players in the prenatal testing and newborn screening sector are launching groundbreaking initiatives using rWGS (rapid Whole Genome Sequencing) technology. This enables prompt and precise detection of genetic disorders in newborns, facilitating immediate diagnostic and remedial steps for better health outcomes. The rWGS technology is a sophisticated genomic method that can sequence a person’s entire genome at a fast pace. It is different from conventional genetic tests that target specific genes or areas; instead, rWGS captures all the DNA present in a person’s genome to spot genetic variations related to diseases or disorders. For example, Rady Children’s Institute for Genomic Medicine, based in the U.S, rolled out a unique program named BeginNGS in June 2022. The program is designed to detect and diagnose nearly 400 genetic disorders with available treatment options before the symptoms show up. BeginNGS is working to optimize genomic sequencing operations and has plans to widen its testing capacity to cover almost 1,000 disorders. The endgame is to make screening for 3.7 million newborns each year a norm in hospitals throughout the country.
Secure Your Global Prenatal Testing & Newborn Screening Market Report Now for Fast and Efficient Delivery!
Which Industry Segments Are Leading the Development and Expansion of the Prenatal Testing & Newborn Screening Market?
The prenatal testing & newborn screening market covered in this report is segmented –
1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End user: Hospitals, Diagnostic centers
Subsegments:
1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening
2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis
Which Geographical Regions Are Pioneering Growth in the Prenatal Testing & Newborn Screening Market?
North America was the largest region in the prenatal testing & newborn screening market in 2023. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Do Experts Define the Scope of the Prenatal Testing & Newborn Screening Market?
Prenatal testing and newborn screening refer to the combined medical practices aimed at assessing the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing includes various assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, allowing for early intervention and treatment to improve health outcomes for infants.
Browse Through More Similar Reports By The Business Research Company:
Gene Editing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
Diagnostic Equipment Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report
Genetic Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
